BETH D. JACOB
Partner
(212) 808-7624 (212) 808-7624
BETH D. JACOB Partner
I enjoy the interplay of science and the law, and my clients look to me to apply the law to complicated scientific and technological concepts in a way that leads to a successful outcome.

Beth Jacob’s practice has focused on the representation of generic pharmaceutical companies in Hatch-Waxman litigation for more than 15 years, where she has appeared on behalf of her clients in courts throughout the United States.

Beth handles other kinds of patent litigation as well, in addition to complex civil litigations.  Her experience includes primary responsibility for a variety of major litigation matters and trials, including representation of The Port Authority of New York and New Jersey in the property damage litigation arising from the collapse of 7 World Trade Center on September 11, 2001.  Beth has been lead counsel at more than 25 trials in federal and state courts, as well as specialized forums such as Surrogate’s Court and arbitrations.  She has argued appeals before the U.S. Court of Appeals of the Second Circuit and the New York Court of Appeals, as well as lower appellate courts.

Beth was appointed by the United States District Court for the Southern District of New York as a mediator in that court’s mandatory mediation program.  She was an assistant district attorney in New York County, assigned to the Rackets Bureau and the Frauds Bureau, where she also originated and headed the tax prosecution unit.

In addition, Beth is committed to providing representation to those individuals and institutions who cannot afford to hire lawyers.  Her pro bono cases have included representing victims of Storm Sandy in insurance claims, habeas petitions on behalf of detainees at Guantanamo Bay, representation of claimants to the 9/11 Victims Compensation Fund, a successful challenge to New York City’s effort to sell off community gardens, successful litigation to prevent New York State from warehousing patients discharged from mental hospitals in nursing homes, and a successful defense (through jury trial) of a house of worship from claims of a disgruntled employee.

Professional Activities

United States District Court for the Southern District of New York mandatory mediation program, court-appointed mediator

Columbia Presbyterian/Weill-Cornell Medical Schools, Residency in Psychiatry and the Law, instructor, 2000–2009

Fordham Law School, New York Practice, adjunct professor, 2001–2006

Apotex Inc. v. Lupin Ltd. (E.D. TX) (paroxetine)

AstraZeneca Pharmaceuticals LP v. Sandoz, Inc. (D.N.J. and Fed. Cir.) (quetiapine)

AstraZeneca LP v. Lek Pharmaceuticals (S.D.N.Y.) (omeprazole)

AstraZeneca Pharmaceuticals LP v. Lupin Pharmaceuticals (D.N.J.) (esomeprazole)

Elan v. Corepharma (E.D.N.Y.) (metaxalone)

Eli Lilly & Co. v. Lupin Ltd., (S.D. Ind.) (prasugrel)

Forest Laboratories, LLC v. Breckenridge Pharmaceutical, Inc. (D. Del.) (asenapine maleate)

Forest Laboratories, LLC v. Lupin Ltd (D.N.J. 2014) (memantine hydrochloride)

G.D. Searle LLC v. Lupin Pharmaceuticals, Inc. (E.D. Va. and Fed. Cir.) (celecoxib)

Kowa Company, Ltd. v. Lupin Limited, (S.D.N.Y.) (pitavastatin calcium)

Orexo AB v. Mylan Inc. (D.N.J.) (zolpidem)

Otsuka Pharmaceutical Co., Ltd. v. Lupin Ltd. (D.N.J.) (aripiprazole)

Sciele Pharma, Inc. v. Lupin Pharmaceuticals (D. Del. and Fed. Cir.) (metformin ER)

Shionogi, Inc. v. Lupin Pharmaceuticals (D. Del.) (metformin)

Shire LLC v. CorePharma, LLC (D.N.J.) (mixed amphetamine salts)

Shire Pharmaceuticals v. Mylan Inc. (S.D.N.Y.) (lanthanum carbonate)

Taro Pharmaceuticals v. Synerx Pharma, LLC (D.N.J.) (malathion lotion)

UCB, Inc. v. CorePharma, LLC (D.N.J.) (methylphenidate)

Pro Bono

Beth is committed to providing representation to those individuals and institutions who cannot afford to hire lawyers. Her pro bono cases have included representing victims of Storm Sandy in insurance claims, habeas petitions on behalf of detainees at Guantanamo Bay, representation of claimants to the 9/11 Victims Compensation Fund, a successful challenge to New York City’s effort to sell off community gardens, litigation to prevent New York State from warehousing patients discharged from mental hospitals in nursing homes, and defense of a house of worship from claims of a disgruntled employee.

The Best Lawyers in America© (Woodward/White, Inc.), Mass Tort Litigation/Class Action, 2014-2017.

Listed in New York Super Lawyers, 2013–2016.

Martindale-Hubbell—A/V Rated

ABA International Section, Life Sciences & Health Law Committee (chair), Bronx Women’s Bar Association

International Bar Association, Healthcare and Life Sciences Committee, chair (2012–2015)

New York City Bar Association, Science and Law Committee, chair, 2012–2014

New York Intellectual Property Law Association

About

Beth Jacob’s practice has focused on the representation of generic pharmaceutical companies in Hatch-Waxman litigation for more than 15 years, where she has appeared on behalf of her clients in courts throughout the United States.

Beth handles other kinds of patent litigation as well, in addition to complex civil litigations.  Her experience includes primary responsibility for a variety of major litigation matters and trials, including representation of The Port Authority of New York and New Jersey in the property damage litigation arising from the collapse of 7 World Trade Center on September 11, 2001.  Beth has been lead counsel at more than 25 trials in federal and state courts, as well as specialized forums such as Surrogate’s Court and arbitrations.  She has argued appeals before the U.S. Court of Appeals of the Second Circuit and the New York Court of Appeals, as well as lower appellate courts.

Beth was appointed by the United States District Court for the Southern District of New York as a mediator in that court’s mandatory mediation program.  She was an assistant district attorney in New York County, assigned to the Rackets Bureau and the Frauds Bureau, where she also originated and headed the tax prosecution unit.

In addition, Beth is committed to providing representation to those individuals and institutions who cannot afford to hire lawyers.  Her pro bono cases have included representing victims of Storm Sandy in insurance claims, habeas petitions on behalf of detainees at Guantanamo Bay, representation of claimants to the 9/11 Victims Compensation Fund, a successful challenge to New York City’s effort to sell off community gardens, successful litigation to prevent New York State from warehousing patients discharged from mental hospitals in nursing homes, and a successful defense (through jury trial) of a house of worship from claims of a disgruntled employee.

Professional Activities

United States District Court for the Southern District of New York mandatory mediation program, court-appointed mediator

Columbia Presbyterian/Weill-Cornell Medical Schools, Residency in Psychiatry and the Law, instructor, 2000–2009

Fordham Law School, New York Practice, adjunct professor, 2001–2006

Experience

Apotex Inc. v. Lupin Ltd. (E.D. TX) (paroxetine)

AstraZeneca Pharmaceuticals LP v. Sandoz, Inc. (D.N.J. and Fed. Cir.) (quetiapine)

AstraZeneca LP v. Lek Pharmaceuticals (S.D.N.Y.) (omeprazole)

AstraZeneca Pharmaceuticals LP v. Lupin Pharmaceuticals (D.N.J.) (esomeprazole)

Elan v. Corepharma (E.D.N.Y.) (metaxalone)

Eli Lilly & Co. v. Lupin Ltd., (S.D. Ind.) (prasugrel)

Forest Laboratories, LLC v. Breckenridge Pharmaceutical, Inc. (D. Del.) (asenapine maleate)

Forest Laboratories, LLC v. Lupin Ltd (D.N.J. 2014) (memantine hydrochloride)

G.D. Searle LLC v. Lupin Pharmaceuticals, Inc. (E.D. Va. and Fed. Cir.) (celecoxib)

Kowa Company, Ltd. v. Lupin Limited, (S.D.N.Y.) (pitavastatin calcium)

Orexo AB v. Mylan Inc. (D.N.J.) (zolpidem)

Otsuka Pharmaceutical Co., Ltd. v. Lupin Ltd. (D.N.J.) (aripiprazole)

Sciele Pharma, Inc. v. Lupin Pharmaceuticals (D. Del. and Fed. Cir.) (metformin ER)

Shionogi, Inc. v. Lupin Pharmaceuticals (D. Del.) (metformin)

Shire LLC v. CorePharma, LLC (D.N.J.) (mixed amphetamine salts)

Shire Pharmaceuticals v. Mylan Inc. (S.D.N.Y.) (lanthanum carbonate)

Taro Pharmaceuticals v. Synerx Pharma, LLC (D.N.J.) (malathion lotion)

UCB, Inc. v. CorePharma, LLC (D.N.J.) (methylphenidate)

Pro Bono

Beth is committed to providing representation to those individuals and institutions who cannot afford to hire lawyers. Her pro bono cases have included representing victims of Storm Sandy in insurance claims, habeas petitions on behalf of detainees at Guantanamo Bay, representation of claimants to the 9/11 Victims Compensation Fund, a successful challenge to New York City’s effort to sell off community gardens, litigation to prevent New York State from warehousing patients discharged from mental hospitals in nursing homes, and defense of a house of worship from claims of a disgruntled employee.

Honors

The Best Lawyers in America© (Woodward/White, Inc.), Mass Tort Litigation/Class Action, 2014-2017.

Listed in New York Super Lawyers, 2013–2016.

Martindale-Hubbell—A/V Rated

Memberships

ABA International Section, Life Sciences & Health Law Committee (chair), Bronx Women’s Bar Association

International Bar Association, Healthcare and Life Sciences Committee, chair (2012–2015)

New York City Bar Association, Science and Law Committee, chair, 2012–2014

New York Intellectual Property Law Association

Practices

Speaking Engagements